OncoMatch/Clinical Trials/Rhabdomyosarcoma (RMS)
Rhabdomyosarcoma (RMS) Clinical Trials
OncoMatch filters Rhabdomyosarcoma (RMS) trials by the molecular markers that determine eligibility — FOXO1, PAX3, FGFR4, CD274, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Rhabdomyosarcoma (RMS) trials
These are the molecular markers most commonly required or evaluated in Rhabdomyosarcoma (RMS) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Rhabdomyosarcoma (RMS) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Children's Oncology Group
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Yizhuo Zhang
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
N.N. Petrov National Medical Research Center of Oncology
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Milton S. Hershey Medical Center
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
University of Texas Southwestern Medical Center
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
St. Jude Children's Research Hospital
How OncoMatch finds Rhabdomyosarcoma (RMS) trials for you
AI reads the protocol
Every Rhabdomyosarcoma (RMS) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Rhabdomyosarcoma (RMS) and mark your biomarker results — FOXO1, PAX3, FGFR4 — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.